A product of independent beta probabilities dose escalation design for dual‐agent phase I trials

DOI10.1002/SIM.6434WikidataQ39958094 ScholiaQ39958094MaRDI QIDQ153908

Adrian Paul Mander, Michael J. Sweeting

Publication date: 29 January 2015

Published in: Statistics in Medicine (Search for Journal in Brave)

Related Items (1)

pipe.design

This page was built for publication: A product of independent beta probabilities dose escalation design for dual‐agent phase I trials